Maryland Senate Bill SB233

Maryland 2025 Regular Session

• Introduced: 1/8/24
• Introduced: 1/8/25
• Refer: 1/8/24
• Refer: 1/8/25

Caption

Prescription Drug Monitoring Program - Dispensers - Veterinarians

Impact

By including veterinarians in the definition of dispensers under the Prescription Drug Monitoring Program, SB233 aims to enhance the monitoring of controlled substances used in veterinary care. This inclusion is essential in combating potential misuse and promoting responsible prescribing and dispensing practices within veterinary medicine. As a result, the bill may lead to improved accountability among veterinarians and better tracking of the use of controlled substances in animal healthcare, which is a growing concern in public health.

Summary

Senate Bill 233 amends the current Prescription Drug Monitoring Program in Maryland, particularly focusing on the inclusion of licensed veterinarians as dispensers of controlled substances. The bill seeks to redefine 'dispenser' to encompass veterinarians who dispense controlled substances in their professional practice. This change acknowledges the role veterinarians play in managing and dispensing medications for animals, thereby aligning veterinary practices with existing state drug monitoring regulations.

Contention

The introduction of SB233 may encounter some contention, particularly regarding concerns over the implications for veterinarians and the potential regulatory burden. Opponents of expanding the scope of the Prescription Drug Monitoring Program might argue that such additions could impose unnecessary complexities on veterinary professionals, hindering their ability to provide timely care. Supporters, however, may emphasize the importance of safeguarding public health by ensuring all professionals who dispense controlled substances are held to high standards and are part of a cohesive monitoring system.